Judge OKs Par's Settlement In Zetia Pay-For-Delay Case

Law360 (March 9, 2020, 6:23 PM EDT) -- A Virginia federal judge has given the final greenlight to a settlement that knocks Par Pharmaceutical out of a massive suit accusing Merck and Glenmark of plotting to hold off generic versions of Zetia and inflating the cholesterol drug's costs.

Par, which got roped into the case as a distributor to wholesale and retail drug buyers, reached the deal with direct purchasers in June to exit the case. The buyers allege that Merck and Glenmark entered into an anti-competitive deal to delay cheaper versions of the medication.

U.S. District Judge Rebecca Beach Smith signed off on the deal's final approval Friday,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!